Didier Hoch

Filings by Didier Hoch span 2 companies, the busiest being OSE Immunotherapeutics and Phaxiam Therapeutics. Over a trading history stretching from 13 June 2024 to 19 September 2025, the count stands at 5 filings.

Both buying and selling appear: 1 purchase, against 1 sale worth €46k. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 1 option exercise.

The record was last updated on 22 September 2025 with an option exercise (€36k) in OSE Immunotherapeutics. The last purchase on record was published on 15 October 2024, which is 732 days ago. Typically, a trade is published a median of 3 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.